UBS Group
QDEL icon

UBS Group’s QuidelOrtho QDEL Stock Holding History

UBS Group’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,000
Closed -$831K – 9953
2024
Q2 		$831K Buy
+25,000
New +$1.02M ﹤0.01% 4582
2023
Q1 		– Sell
-39,156
Closed -$3.35M – 10224
2022
Q4 		$3.35M Buy
+39,156
New +$3.32M ﹤0.01% 2865
2021
Q3 		– Sell
-200
Closed -$26K – 9974
2021
Q2 		$26K Buy
+200
New +$23.5K ﹤0.01% 7078

Other funds holding QDEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

UBS Group's QDEL Position: Q1 2026 in Review

UBS Group increased its QuidelOrtho (QDEL) stake by 14% in Q1 2026, buying an estimated $1.61M and bringing the position to 542,002 shares worth $8.91M. The position accounts for ﹤0.01% of the portfolio, ranked #3485.

UBS Group first reported a position in QDEL in Q4 2014 and has held it in 46 quarters since. The position peaked at $15.9M in Q3 2025. 238 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • UBS Group held 542,002 shares of QuidelOrtho worth $8.91M as of Q1 2026.
  • UBS Group bought 65,385 QuidelOrtho shares in Q1 2026, an estimated $1.61M.
  • QuidelOrtho made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3485 holding.
  • UBS Group first reported a position in QuidelOrtho in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's QuidelOrtho position peaked at $15.9M in Q3 2025.
  • 238 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.